Raf
Las quinasas Raf son componentes clave de la vía de señalización MAPK/ERK, desempeñando un papel crítico en la transmisión de señales desde la membrana celular hasta el núcleo. La activación de Raf conduce a la fosforilación de MEK, que posteriormente activa ERK, influyendo en la división, diferenciación y supervivencia celular. Las mutaciones en Raf, particularmente en B-Raf, están asociadas con varios tipos de cáncer, lo que convierte a Raf en un objetivo crucial en la terapia contra el cáncer. En CymitQuimica, ofrecemos una variedad de inhibidores y moduladores de Raf para apoyar su investigación en oncología, transducción de señales y desarrollo terapéutico.
Productos de "Raf"
Ordenar por
Sorafenib
CAS:Sorafenib (Bay 43-9006) is a multikinase inhibitor that inhibits Raf-1, B-Raf, VEGFR2, VEGFR3, VEGFR4, PDGFRβ, FLT3, c-Kit, and others (IC50=6/22/90/15/20/20/57Fórmula:C21H16ClF3N4O3Pureza:98% - 99.89%Forma y color:SolidPeso molecular:464.82Doramapimod
CAS:Doramapimod (BIRB 796) is a highly potent inhibitor of p38 MAPK (Kd: 0.1 nM), but weakly inhibits c-RAF, Fyn, Lck, ERK-1, SYK, IKK2, and ZAP-70.Fórmula:C31H37N5O3Pureza:97.73% - 98.80%Forma y color:SolidPeso molecular:527.66Ref: TM-T6277
1g562,00€5mg37,00€10mg55,00€25mg79,00€50mg92,00€100mg127,00€200mg225,00€500mg379,00€1mL*10mM (DMSO)44,00€PLX7904
CAS:PLX7904 (PB04), a selective RAF inhibitor, blocks ERK1/2 in mutant BRAF melanoma without activating it in RAS mutants.Fórmula:C24H22F2N6O3SPureza:96.27% - 96.27%Forma y color:SolidPeso molecular:512.53SOS1-IN-15
CAS:SOS1-IN-15 is an orally active and potent SOS1 inhibitor with potential antitumor activity.SOS1-IN-15 is used in the study of colon cancer.Fórmula:C28H27F3N6O2Pureza:98.32%Forma y color:SolidPeso molecular:536.548L-779450
CAS:L-779450, an effective, ATP-competitive Raf kinase inhibitor (IC50: 10 nM) , displays >7, >30 and >70-fold selectivity over p38α, GSK3β and Lck respectively.Fórmula:C20H14ClN3OPureza:≥95%Forma y color:SolidPeso molecular:347.8Exarafenib
CAS:Exarafenib (RAF/KIN_2787) is an oral pan-RAF inhibitor with antitumor properties, targeting MAPK signaling in cancer research.Fórmula:C26H34F3N5O3Pureza:98.36% - 99.39%Forma y color:SolidPeso molecular:521.58B-Raf IN 16
CAS:B-Raf IN 16, a BRAF inhibitor, belongs to cyclic iminopyrimidine derivatives and can be used for cancer or tumour research.Fórmula:C20H19N5O3SPureza:98.59% - 99.56%Forma y color:SolidPeso molecular:409.46GW 5074
CAS:GW 5074 (Raf1 Kinase Inhibitor I)(IC50=9 nM) is an effective and specific c-Raf inhibitor.Fórmula:C15H8Br2INO2Pureza:99.32%Forma y color:SolidPeso molecular:520.94Ref: TM-T6525
2mg43,00€5mg59,00€10mg88,00€25mg134,00€50mg168,00€100mg197,00€200mg283,00€1mL*10mM (DMSO)73,00€TBAP-001
CAS:TBAP-001 is a RAF kinase inhibitor, with an IC50 of 62 nM in BRAF V600E kinase assay and an IC50 of 18 nM in Cell-Based Phosho-ERK Assay.Fórmula:C27H23F2N7O3Pureza:99.3%Forma y color:SolidPeso molecular:531.51Ref: TM-T9693
1mg48,00€5mg97,00€10mg156,00€25mg271,00€50mg408,00€100mg567,00€200mg748,00€1mL*10mM (DMSO)113,00€TAK-632
CAS:TAK-632 is a potent pan-Raf inhibitor.Fórmula:C27H18F4N4O3SPureza:98% - 98.92%Forma y color:SolidPeso molecular:554.52Sorafenib tosylate
CAS:Sorafenib tosylate (Bay 43-9006) is a potent multikinase inhibitor (IC50s: 6/20/22 nM for Raf-1/VEGFR-3/B-Raf).Fórmula:C21H16ClF3N4O3·C7H8O3SPureza:99.2% - 99.94%Forma y color:White To Off-White Crystalline PowderPeso molecular:637.03B-Raf IN 15
CAS:B-Raf IN 15 is a BRAF inhibitor that inhibits BRAFWT and BRAFV600E and can be used to study melanoma and cancer.Fórmula:C19H15N3OSPureza:98%Forma y color:SolidPeso molecular:333.41PLX-4720
CAS:PLX-4720 is a potent and selective B-Raf (V600E) inhibitor designed to block the ATP-binding site of oncogenic B-Raf.Cost-effective and quality-assured.Fórmula:C17H14ClF2N3O3SPureza:97.78% - 99.83%Forma y color:SolidPeso molecular:413.83Regorafenib Hydrochloride
CAS:Regorafenib HCl (BAY73-4506) is an oral inhibitor targeting angiogenic, stromal, and cancer kinases with strong antitumor effects.Fórmula:C21H16Cl2F4N4O3Pureza:99.56%Forma y color:SolidPeso molecular:519.28Vem-L-Cy5
Vem-L-Cy5 (compound 3), a Vemurafenib-based BRAF inhibitor conjugated with the near-infrared (NIR) fluorophore cyanine-5 (Cy5), selectively targets the BRAFFórmula:C63H68F5N7O9SPureza:98%Forma y color:SolidPeso molecular:1194.31AZ 628
CAS:AZ628 is a new pan-Raf inhibitor for BRAF, BRAFV600E, and c-Raf-1 with IC50 of 105 nM, 34 nM and 29 nM, also inhibits VEGFR2, DDR2, Lyn, Flt1, FMS, etc.Fórmula:C27H25N5O2Pureza:98.54%Forma y color:SolidPeso molecular:451.52Belvarafenib
CAS:Belvarafenib (HM95573) is a potent pan-RAF inhibitor with antitumor activity and inhibits B-RAF, B-RAFv600E, and C-RAF.Cost-effective and quality-assured.Fórmula:C23H16ClFN6OSPureza:99.44% - ≥98%Forma y color:SolidPeso molecular:478.93Uplarafenib
CAS:Uplarafenib (B-Raf IN 10), a potent BRAF inhibitor (IC50: 50-100 nM), exhibits antitumor effects on solid cancers.Fórmula:C22H21F3N4O4SPureza:99.85%Forma y color:SolidPeso molecular:494.49Ref: TM-T63333
1mg95,00€5mg202,00€10mg298,00€25mg630,00€50mg948,00€100mg1.644,00€500mg3.307,00€1mL*10mM (DMSO)224,00€Plx-4032
CAS:Plx-4032 (Vemurafenib) is a small-molecule B-Raf inhibitor for the potential treatment of malignant melanoma.Fórmula:C23H18ClF2N3O3SPureza:98.53% - 99.36%Forma y color:SolidPeso molecular:489.92Regorafenib
CAS:Regorafenib (BAY 73-4506) is a multi-targeted receptor tyrosine kinase inhibitor that inhibits RET, C-RAF, VEGFR2, c-Kit, VEGFR1, and PDGFRβ and is orallyFórmula:C21H15ClF4N4O3Pureza:98% - 99.95%Forma y color:SolidPeso molecular:482.82Ref: TM-T1792
5mg35,00€10mg51,00€25mg80,00€50mg96,00€100mg144,00€200mg185,00€500mg309,00€1mL*10mM (DMSO)57,00€
